Learn More
Medchemexpress LLC Berubicin (RTA 744 free base) | 677017-23-1 | 87.8% | 633.64 | 5 MG

Supplier: Medchemexpress LLC HY149425MG
Berubicin is a doxorubicin analog that can cross the blood-brain barrier. It inhibits P-gp and MRP1-mediated efflux and suppresses glioblastoma multiforme (GBM). This compound exerts toxic effects on leukemia cells by activating nuclear factor κB (NF-κB) and induces apoptosis in neuroblastoma cells, making it suitable for studies related to nervous system tumors.
- Inhibits P-gp and MRP1-mediated efflux.
- Suppresses glioblastoma multiforme (GBM).
- Activates nuclear factor κB (NF-κB) and induces apoptosis in leukemia and neuroblastoma cells.
- More effective than doxorubicin in inhibiting SH-SY5Y cell growth.
- Prolongs the survival time of intracranial orthotopic glioma models in mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.